WealthShield Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
WealthShield Partners's LLY Position: Q1 2026 in Review
WealthShield Partners reduced its Eli Lilly (LLY) stake by 2.9% in Q1 2026, selling an estimated $91.2K and leaving 3,032 shares worth $2.79M. The position accounts for 0.31% of the portfolio, ranked #89.
WealthShield Partners first reported a position in LLY in Q2 2020 and has held it in 22 quarters since. The position peaked at $3.44M in Q2 2024. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- WealthShield Partners held 3,032 shares of Eli Lilly worth $2.79M as of Q1 2026.
- WealthShield Partners sold 90 Eli Lilly shares in Q1 2026, an estimated $91.2K.
- Eli Lilly made up 0.31% of WealthShield Partners's portfolio in Q1 2026, its #89 holding.
- WealthShield Partners first reported a position in Eli Lilly in Q2 2020 and has held it in 22 quarters since.
- WealthShield Partners's Eli Lilly position peaked at $3.44M in Q2 2024.
- 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.